NewsRoom Articles - Page 1098 of 1254

TuesdayJun 06, 2017 4:30 pm

Kindred Biosciences, Inc. (NASDAQ: KIN) Starts Presentation at LD Micro 2017 Invitational

Kindred Biosciences (NASDAQ: KIN) is a development-stage biopharmaceutical company that focuses on the development of therapies for pets. The company’s product pipeline consists of small molecules and biologics for a range of indications in dogs, cats and horses. Its lead product candidates include Zimeta, a dipyrone injection for the control of pyrexia (fever) in horses; and Mirataz, a mirtazapine transdermal ointment for the management of weight loss in cats. The company's other small molecule product candidates consist of KIND-014 for the treatment of equine gastric ulcers in horses; and KIND-015 for the management of clinical signs associated with equine metabolic…

TuesdayJun 06, 2017 4:00 pm

Atossa Genetics, Inc. (NASDAQ: ATOS) Starts Presentation at LD Micro 2017 Invitational

Atossa Genetics (NASDAQ: ATOS) is a clinical-stage pharmaceutical company engaged in the development of novel therapeutics and delivery methods to treat breast cancer and other breast conditions. The company’s leading program utilizes patented intraductal microcatheters, which deliver pharmaceuticals through the breast milk ducts. In March 2016, Atossa initiated a Phase 2 clinical study of these microcatheters to deliver fulvestrant as a potential treatment for ductal carcinoma in-situ, or DCIS, and breast cancer. For more information, visit the company’s website at www.atossagenetics.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides to users (1) access to our news aggregation and…

TuesdayJun 06, 2017 4:00 pm

A-Mark Precious Metals, Inc. (NASDAQ: AMRK) Starts Presentation at LD Micro 2017 Invitational

A-Mark Precious Metals (NASDAQ: AMRK) operates as a precious metals trading company worldwide. The company offers gold, silver, platinum and palladium in the form of bars, plates, powder, wafers, grains, ingots and coins, as well as distributes gold and silver coins and bars from sovereign and private mints. It also provides loans on precious metals, rare coins, and other collectibles collateral to coin dealers, collectors and investors; storage solutions for precious metals and numismatic coins for financial institutions, dealers, investors and collectors; and a range of logistics services. For more information, visit the company's website at www.amark.com. About NetworkNewsWire NetworkNewsWire…

TuesdayJun 06, 2017 4:00 pm

CV Sciences, Inc. (CVSI) Starts Presentation at LD Micro 2017 Invitational

CV Sciences (OTC: CVSI) is a life science company that focuses on developing and commercializing novel therapeutics utilizing synthetic Cannabidiol (CBD). The company operates through two segments: Specialty Pharmaceutical and Consumer Product. It also manufactures, markets and sells plant-based CBD products under PlusCBD brand for a range of market sectors, including nutraceutical, beauty care, specialty foods, and vape. The company was formerly known as CannaVEST Corp. and changed its name to CV Sciences in January 2016. CV Sciences was founded in 2010 and is based in Las Vegas, Nevada. For more information, visit the company's website at www.cvsciences.com. About NetworkNewsWire…

TuesdayJun 06, 2017 3:30 pm

Exactus, Inc. (EXDI) Starts Presentation at LD Micro 2017 Invitational

Exactus (OTC: EXDI) is a life science company that engages in developing point-of-care (POC) diagnostics for measuring proteolytic enzymes in the blood. It develops products to make patient data available to healthcare providers in a way that is unmatched. Exactus addresses healthcare gaps with easy-to-use, portable devices that reduce the time required to return analysis on patient blood and collagenase activity. Its POC diagnostic tools use patented technology to analyze biometric markers in a single drop of blood, revealing insights into patient health. The company is based in Glen Allen, Virginia. For more information, visit the company's website at www.exactusinc.com…

TuesdayJun 06, 2017 3:30 pm

Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) Starts Presentation at LD Micro 2017 Invitational

Perma-Fix Environmental (NASDAQ: PESI) is a nuclear services company and provider of nuclear and mixed waste management services. The company's nuclear waste services include management and treatment of radioactive and mixed waste for hospitals, research labs and institutions, federal agencies, including the Department of Energy ("DOE"), the Department of Defense ("DOD"), and the commercial nuclear industry. Perma-Fix Environmental’s nuclear services group provides project management, waste management, environmental restoration, decontamination and decommissioning, new build construction, and radiological protection, safety and industrial hygiene capability to our clients. The company operates four nuclear waste treatment facilities and provides nuclear services at DOE, DOD,…

TuesdayJun 06, 2017 3:30 pm

Legacy Education Alliance, Inc. (LEAI) Starts Presentation at LD Micro 2017 Invitational

Legacy Education Alliance (OTCQB: LEAI) is an international leader in providing practical, high-quality and value-based education training on the subjects of personal finance, entrepreneurship, real estate and financial markets investing strategies and techniques. Founded in 1996, the company has become a global enterprise supported by about 200 employees and has cumulatively served over 2 million students from more than 150 countries and territories. Legacy Education Alliance offers training through various brands, including Rich Dad® Education, Rich Dad® Stock Education, Making Money from Property with Martin RobertsTM, Brick Buy BrickTM, Building Wealth, Robbie Fowler Property AcademyTM, Women in WealthTM, The Independent…

TuesdayJun 06, 2017 3:05 pm

India Globalization Capital, Inc. (NYSE: IGC) Targets Human and Veterinary Epilepsy with Innovative Cannabinoid Therapy

With about 50 million people affected worldwide, drug-resistant epilepsy, or refractory epilepsy, is a very serious condition for which a medical solution has not yet been found, but the therapeutic benefits of phytocannabinoid-based therapies for seizures have been coming under increased scrutiny lately. There is mounting evidence that cannabinoid extracts, and in particular cannabidiol (CBD), can have a positive impact on epilepsy patients and alleviate seizures, as indicated by recent research. Companies such as India Globalization Capital, Inc. (NYSE MKT: IGC) are at the forefront of discovering cannabinoid-based epilepsy treatments for humans and animals alike, by developing innovative formulations that…

TuesdayJun 06, 2017 3:00 pm

CytoDyn, Inc. (CYDY) Starts Presentation at LD Micro 2017 Invitational

CytoDyn (OTC: CYDY) is a biotechnology company focused on the clinical development and potential commercialization of humanized monoclonal antibodies for the treatment and prevention of Human Immunodeficiency Virus (HIV) infection. The company has one of the leading monoclonal antibodies under development for HIV infection, PRO 140, which has finished phase 2 clinical trials with demonstrated antiviral activity in man. PRO 140 blocks the HIV co-receptor CCR5 on T-cells that prevents viral entry. Clinical trial results thus far indicate that PRO 140 does not negatively affect the normal immune functions that are mediated by CCR5. Results from six phase 1 and…

TuesdayJun 06, 2017 3:00 pm

Cellectar Biosciences, Inc. (NASDAQ: CLRB) Starts Presentation at LD Micro 2017 Invitational

Cellectar Biosciences (NASDAQ: CLRB) is engaged in the development of targeted phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. It offers CLR 131, a PDC radiotherapeutic product candidate currently being evaluated in a phase I study for the treatment of relapse or refractory multiple myeloma; CLR 125, a cancer-targeting radiotherapeutic is under pre-clinical investigation for the treatment of micrometastatic disease ; CLR 124, a cancer-targeting positron emission tomography (PET) imaging PDC for the selective detection of tumors and metastases in a broad range of cancers; and CLR 1502, a cancer-targeting NIR-fluorophore optical imaging PDC for intraoperative tumor…

Financial news and publishing for public and private companies

Contact us: 212.418.1217

Kindred Biosciences, Inc. (NASDAQ: KIN) Starts Presentation at LD Micro 2017 Invitational

Atossa Genetics, Inc. (NASDAQ: ATOS) Starts Presentation at LD Micro 2017 Invitational

A-Mark Precious Metals, Inc. (NASDAQ: AMRK) Starts Presentation at LD Micro 2017 Invitational

CV Sciences, Inc. (CVSI) Starts Presentation at LD Micro 2017 Invitational

Exactus, Inc. (EXDI) Starts Presentation at LD Micro 2017 Invitational

Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) Starts Presentation at LD Micro 2017 Invitational

Legacy Education Alliance, Inc. (LEAI) Starts Presentation at LD Micro 2017 Invitational

India Globalization Capital, Inc. (NYSE: IGC) Targets Human and Veterinary Epilepsy with Innovative Cannabinoid Therapy

CytoDyn, Inc. (CYDY) Starts Presentation at LD Micro 2017 Invitational

Cellectar Biosciences, Inc. (NASDAQ: CLRB) Starts Presentation at LD Micro 2017 Invitational

NetworkNewsWire Currently Accepts

NetworkNewsWire

Financial news and publishing for public and private companies

Contact us: 212.418.1217

NetworkNewsWire Currently Accepts

Company Search

Site Search